Search

Search results

1. Stronger intellectual property for pharmaceuticals would benefit Canadians

   Appeared in the Globe and Mail Economy Lab Canada's lagging intellectual property (IP) protections for pharmaceutical innovators are a key issue to be settled in the Comprehensive Economic and Trade Agreement (CETA) negotiations with the European ...